# Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis

> **NCT01271517** · PHASE4 · UNKNOWN · sponsor: **Karolinska Institutet** · enrollment: 120 (actual)

## Conditions studied

- Diabetes Mellitus Type 1

## Interventions

- **DRUG:** NPH insulin
- **DRUG:** Glargine
- **DRUG:** Detemir

## Key facts

- **NCT ID:** NCT01271517
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** 2011-03
- **Final completion:** —
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2011-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01271517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01271517, "Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01271517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*